SEI Investments’s KalVista Pharmaceuticals KALV Stock Holding History

SEI Investments's KALV Position: Q2 2026 in Review

SEI Investments sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 12,143 shares — an estimated $244K sold.

SEI Investments first reported a position in KALV in Q3 2025 and held it in 3 quarters. The position peaked at $244K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

• SEI Investments reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
• SEI Investments sold 12,143 KalVista Pharmaceuticals shares in Q2 2026, an estimated $244K.
• SEI Investments first reported a position in KalVista Pharmaceuticals in Q3 2025 and held it in 3 quarters.
• SEI Investments's KalVista Pharmaceuticals position peaked at $244K in Q1 2026.
• 1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.